IngredientsRanunculus occidentalis, the western buttercup, is a species of buttercup found in the western regions of North America. It was formally described by Thomas Nuttall, with the scientific name published in Flora of North America, volume 1, in 1838. The genus name Ranunculus is placed in the family Ranunculaceae (the buttercup or crowfoot family). The scientific name Ranunculus is derived from the Latin word rana, meaning "frog," as these plants often thrive in damp environments where frogs might be found. The specific epithet occidentalis refers to its distribution in the western regions of North America.
The species is sometimes written as Ranunculus occidentalis Nutt. in formal botanical contexts, acknowledging Nuttall as the describing authority. It is very closely related to the California buttercup (R. californicus), and in early growth phases can also be confused with the invasive creeping buttercup (R. repens). Because this species has such a broad distribution and multiple varieties, it is commonly misidentified. This plant is similar to, and sometimes difficult to distinguish from, the California buttercup (Ranunculus californicus).
The variety occidentalis occurs chiefly west of the Cascades crest and east in the Columbia River Gorge in Washington, ranging from Alaska to California, and east to the Blue Mountains in Oregon. Multiple botanical varieties within R. occidentalis are recognized in the botanical literature, including R. occidentalis var. eisenii (Kellogg) Gray, reflecting the considerable morphological variation across the species' range.
It is a perennial growing to 0.6 m (2 ft), in flower from May to July, and the species is hermaphrodite (possessing both male and female organs), pollinated by insects. The stem is upright, usually branched, and hollow, with soft hairs. Western Buttercup averages 1 ft. in height, with leaves either smooth or softly hairy; basal leaves are much lobed and dissected, while the stem leaves are less so. Five to eight bright yellow petals surround a center of yellow stamens and pistils, with the flowers terminal on the stems. The plant is a perennial herb; stems are erect to reclining, up to about 2 feet long, and the fruit is an achene.
Its distribution extends from Alaska through British Columbia and Alberta to central California. It is native to Alaska and extends south through western Washington and Oregon to California and Nevada, and also into Alberta, Canada. The flower can be seen in open meadows, forests, and other generally flat areas up to an elevation of 2,200 metres (7,200 ft).
R. occidentalis prefers seasonally moist soils in a variety of habitats from coastal prairies and bluffs to disturbed areas, meadows, and forested areas. It is generally associated with wetland areas, although it will tolerate seasonal drought. It is suitable for light (sandy), medium (loamy), and heavy (clay) soils with mildly acid, neutral, or mildly alkaline pH, can grow in semi-shade or full sun, and prefers moist soil.
Western buttercup is not manufactured into modern standardized dietary supplement forms (such as capsules, extracts, or tinctures sold commercially) in the manner of many mainstream botanical supplements. No commercial supplement monographs from the NIH Office of Dietary Supplements, NCCIH, EMA, ESCOP, or the German Commission E have been issued specifically for Ranunculus occidentalis. The plant's documented human uses have been primarily ethnobotanical — specifically, the preparation of edible seeds and the use of plant juices for non-oral purposes. The edible part documented for this species is the seed, cooked, and used as piñole — either on its own or mixed with other seeds. The seed must be parched in order to remove an acrid principle.
Western buttercup has been noted as an important species to tribes throughout its range. In northern California and southern Oregon, its blooms are said to mark the coming of the summer salmon runs. Many tribes ground the seeds of the buttercup and mixed them with other seeds to make pinole (a flour-like staple), and the Aleut noted the juices of its blooms are poisonous.
Specifically regarding the two best-documented indigenous relationships with this species:
The juice from the flowers was used as a poison by Native North American Indians. The toxins are present in all parts of the plant and can be destroyed by heat or by drying. Many if not all plants in this genus also have a strongly acrid juice that can cause blistering to the skin.
The seed has also been recorded as edible when cooked, used as piñole either on its own or mixed with other seeds, and the seed must be parched in order to remove its acrid principle.
While the ethnobotanical record specific to R. occidentalis is limited primarily to the food/poison uses above, other members of the broader Ranunculus genus have extensive traditional medicinal documentation that provides important context for understanding the plant family's historical role. Although many species belonging to the family are well-known for being highly poisonous, a number of them have been used for centuries as medicines, spices, and vegetables after cautious processing to reduce their toxicity. In folk medicine, Ranunculaceae species have been used in heat-clearing, detoxification, and as a natural remedy for malaria and various ailments related to oxidative stress such as asthma, arthritis, bronchitis, cancer, gout, and rheumatism.
Ranunculus sceleratus L., an annual herbaceous plant, has been listed among the top herbs in the Shennong Traditional Herbal Scriptures, written in the Western Han Dynasty. The Compendium of Materia Medica notes that fresh R. sceleratus could be pasted onto acupuncture points overnight to cure jaundice induced by malaria. These traditional uses — while not for R. occidentalis directly — illustrate how related Ranunculus species have been embedded in Asian ethnomedicinal systems for millennia.
The genus Ranunculus is used to exert anti-inflammatory, anticancer, antitubercular, antibacterial, and antimalarial actions, and traditional Chinese medicine characteristics, like clearing away heat and detoxification, make this genus significant in ethnic medicine.
The most chemically and pharmacologically significant feature of R. occidentalis and related species is a tightly coupled biosynthetic cascade involving three compounds: ranunculin, protoanemonin, and anemonin.
Ranunculin is the primary precursor compound. Ranunculin, a glucoside, serves as a chemotaxonomic marker in Ranunculaceae plants. Ranunculin is a glucoside in which glucose is the specific sugar attached to its aglycone protoanemonin. It is very stable in acidic medium and in fresh plant tissues, but in alkaline solution or in damaged plant cells it is hydrolyzed into the unstable toxin protoanemonin and glucose. Ranunculin is found in many members of the buttercup family, including species of Helleborus, Anemone, Clematis, and most commonly Ranunculus. Glycosides are common in plants, where they serve as defense mechanisms against herbivores and microorganisms.
Protoanemonin is the immediate toxic intermediate. When these plants are damaged, the enzyme β-glucosidase triggers the conversion of ranunculin into protoanemonin through hydrolysis. Protoanemonin (sometimes called anemonol or ranunculol) is a toxin whose glycosidic precursor ranunculin is found in many plants of the buttercup family (Ranunculaceae). When the plant is wounded or macerated, ranunculin is enzymatically broken down into glucose and protoanemonin.
This toxin's ability to inhibit both gram-positive and gram-negative bacteria is linked to the presence of a 5-membered lactone ring with a highly reactive double bond system. Protoanemonin is an irritant to skin, eyes, and mucosal surfaces; it binds sulphydryl groups and disrupts disulphide bonds, leading to disruption of skin architecture and formation of bullae.
Anemonin is the stable end-product of the cascade. Subsequently, protoanemonin undergoes cyclodimerization to form anemonin. Anemonin is a dibutenolide natural product found in members of the buttercup family (Ranunculaceae) such as Helleborus niger, Ranunculus bulbosus, R. ficaria, R. sardous, R. sceleratus, and Clematis hirsutissima. Originally isolated in 1792 by M. Heyer, it is the dimerization product of the toxin protoanemonin.
The inherent instability of ranunculin and the rapid dimerization of protoanemonin render them unsuitable for use in biological assays. Conversely, anemonin stands out as the optimal molecule for bioassays and demonstrates diverse biological properties, including anti-inflammatory, anti-infective, and anti-oxidant effects.
Anemonin stands out as the optimal molecule for bioassays and demonstrates diverse biological properties, including anti-inflammatory, anti-infective, and anti-oxidant effects. Among these, anemonin exhibits the greatest promise in addressing arthritis, cerebral ischemia, and ulcerative colitis. Its potential medical uses are enhanced by its capacity to inhibit nitric oxide synthesis and successfully counteract lipopolysaccharide-induced inflammation.
Anemonin is considered one of the likely active agents in plants used in Chinese medicine as an anti-inflammatory and in Native American medicine as a horse stimulant.
Although direct phytochemical analyses of R. occidentalis specifically are scarce in the peer-reviewed literature, the chemistry of the genus is well described and applies across related species:
The genus Ranunculus contains flavonoids, organic acids, coumarins, lactones, glycosides, sterols, polysaccharides, and trace elements. The genus Ranunculus L. contains 413 species and is the biggest genus in the family Ranunculaceae Juss.
The main constituents of R. sceleratus L. are flavonoids, steroids such as pyrogallol tannins, and the glycoside ranunculin. Phytochemical analysis of R. muricatus L. revealed the presence of saponins, tannins, phenols, flavonoids, alkaloids, cardiac glycosides, anthocyanins, carbohydrates, coumarins, and phytosterols. Compounds belonging to the classes of flavonoid and phenolics (flavonol glycosides of quercetin, kaempferol, isorhamnetin, and their aglycones) have been previously identified in R. sardous.
Over the past few years, several chemical constituents have been isolated from related Ranunculus species, including emodin, scoparone, isoscopoletin, protocatechualdehyde, protocatechuic acid, hexadecanoic acid, β-sitosterol, stigmast-4-ene-3,6-dione, stigmasterol, 1-docosene, and stigmast-5-en-3-ol.
Important prefatory note on evidence scope: No published human clinical trials, randomized controlled trials, or systematic reviews are known to focus on Ranunculus occidentalis specifically. The scientific pharmacological literature is directed almost entirely at other Ranunculus species (R. sceleratus, R. muricatus, R. japonicus, R. ternatus, R. arvensis, etc.), and at the isolated compounds shared across the genus — particularly anemonin and protoanemonin. The following sections report what the evidence base for these compounds and related species shows, clearly labelled as to study type and species studied.
Evidence level: Preclinical (in vitro and animal models); no human clinical data for R. occidentalis or isolated anemonin in humans.
The genus Ranunculus has been reported to possess anti-inflammatory, analgesic, antiviral, antibacterial, antiparasitic, and antifungal activities, possibly due to the presence of anemonin and other constituents.
Protoanemonin and anemonin have shown fungicidal, antimicrobial, antimutagenic, and antipyretic properties, and have been used for ethnopharmacological purposes in many countries.
A pharmacological investigation of R. sceleratus published in Journal of Ethnopharmacology found that the methanol extract of Ranunculus sceleratus has the ability to interact directly with DNA, a fact that may be related with the previously cited antimutagenic properties of protoanemonin. When human platelets were incubated in the presence of the methanol extract, the release of both 12(S)-HHTrE and 12(S)-HETE was inhibited — findings that are consistent with an anti-inflammatory mechanism but remain in vitro.
A broad spectrum of pharmacological activities, including anti-inflammatory, analgesic, antimicrobial, antiparasitic, and antitumor properties, have been reported for various Ranunculaceae species. These findings, however, are based on preclinical models and have not been translated to R. occidentalis-specific human studies.
Evidence level: Animal models only; no human data.
One of the most studied potential applications of anemonin in preclinical science is neuroprotection. Researchers aimed to evaluate the potential neuroprotective effect and the underlying mechanism of anemonin against cerebral ischemia and reperfusion (I/R) injury. In this animal study, anemonin was administered to rats by the intraperitoneal route once daily for 7 days before middle cerebral artery occlusion (MCAO). Focal cerebral ischemia was induced by 90 min of MCAO followed by 24 h of reperfusion. Pretreatment with anemonin significantly reversed levels of biochemical parameters, reduced cerebral infarct size, and improved the neurologic score in cerebral ischemic animals. Additionally, a wide distribution of anemonin in plasma and brain tissues and the brain-to-plasma partition coefficient (Ri) ratio of 0.7 at 90 min indicated that this compound could penetrate the blood-brain barrier (BBB). These results showed that pretreatment with anemonin provided significant protection against cerebral I/R injury in rats, at least in part through its antioxidant action and consequent inhibition of apoptosis.
These are promising preclinical results but have not been replicated in human trials.
Evidence level: In vitro and animal models; one PMC-indexed animal study on antitrypanosomal activity of anemonin.
Anemonin displayed significant antileishmanial activity with IC₅₀ values of 1.33 nM and 1.58 nM against promastigotes and 1.24 nM and 1.91 nM against amastigotes of L. aethiopica and L. donovani, respectively. It also showed moderate activity against adult S. mansoni and newly transformed schistosomules (49% activity against adult S. mansoni at 10 µM and 41% activity against NTS at 1 µM).
In a separate in vivo animal study: at a concentration of 4 mg/ml, the hydro-distilled extract drastically reduced motility of trypanosomes within 20 minutes. Similarly, anemonin at the same concentration completely immobilized trypanosomes within 5 minutes of incubation. In the in vivo antitrypanosomal assay, anemonin eliminated parasites at all the tested doses (8.75, 17.00, and 35.00 mg/kg/day) and prevented relapse, while in diminazene aceturate-treated mice the parasites reappeared on days 12 to 14.
The results obtained indicate that anemonin has the potential to be used as a template for designing novel antileishmanial and antischistosomal pharmacophores. All current evidence for these antiparasitic effects is preclinical.
Evidence level: In vitro only; no human clinical data.
The pharmacological properties of the genus Ranunculus have been largely attributed to the presence of γ-lactones; protoanemonin, for example, has been shown to possess fungicidal, antimicrobial, and antimutagenic properties.
An electron microscopy study examined protoanemonin's antifungal activity at the cellular level: The ranunculaceous derivative protoanemonin was studied as an antifungal agent on the dermatophyte Microsporum cookei, and the ultrastructural changes it brought about in this fungus were observed with both transmission and scanning electron microscopes. The main anomalies noted were abnormally shaped hyphae and, within the cytoplasm, multimembranous bodies that were irregular in shape and size, and tubules of 25 and 60 nm in diameter. Mitochondria, nuclei, and vacuoles were also variously affected by protoanemonin. The observed cellular alterations can be considered the result of a protoanemonin interaction with cytoplasmic microtubules.
Protoanemonin's ability to inhibit both gram-positive and gram-negative bacteria is linked to the presence of a 5-membered lactone ring with a highly reactive double bond system.
Evidence level: In vitro; no human data for R. occidentalis specifically.
Studies on the biological activity of crude or purified compounds from various Ranunculus species have provided new insights into antioxidant, immunomodulatory, and anticarcinogenic properties. Antioxidant activity has been studied in vitro for several species, and the anti-inflammatory and analgesic effects of plants used in traditional medicine applications have been confirmed, though there is a need for more diverse studies on the chemical and pharmacological activities of highly purified molecules from Ranunculus species extracts to understand the mechanisms underlying their activities and identify novel drug candidates.
Evidence level: Preclinical and folk medicine reports only; no human clinical trials.
Many studies have demonstrated anemonin's potential for the treatment of inflammatory and cardiovascular diseases, including cerebral ischemia, ulcerative colitis, arthritis, and inflammatory bone loss. These conclusions are drawn from in vitro and animal research, not human trials. The contact dermatitis caused by Ranunculus is reported at home and abroad, especially when whole-grass external treatment is used for rheumatism and arthritis. The causative compounds are protoanemonin and sesquiterpene lactones. This indicates that topical use for joint conditions, while practiced in some folk traditions, carries meaningful risk.
Evidence level: Preclinical (in vitro/animal) for anemonin; no human data.
Anemonin's potential for addressing ulcerative colitis has been studied using cellular and animal models. Research has documented its anti-inflammatory mechanism via regulation of protein kinase C-θ in intestinal inflammation, as cited in the PMC literature. Anemonin exhibits the greatest promise in addressing arthritis, cerebral ischemia, and ulcerative colitis; its potential medical uses are enhanced by its capacity to inhibit nitric oxide synthesis and successfully counteract lipopolysaccharide-induced inflammation.
Based on the peer-reviewed ethnopharmacological and phytochemical literature reviewed above, the following body systems are implicated in the scientific (mostly preclinical) research on Ranunculus genus compounds relevant to R. occidentalis:
No standardized dosage regimens exist for Ranunculus occidentalis as a dietary supplement. The following doses are reported only as used in preclinical research on anemonin and related compounds in the Ranunculus family — they are not clinical recommendations and are reported solely as found in the cited sources:
For the traditional food use of the seeds, no standardized preparation or dose has been documented in the reviewed literature beyond the indigenous practice of parching and grinding seeds for pinole, with no quantified intake recorded.
Intoxications caused by Ranunculus are due mainly to the irritant effects of protoanemonin. Formed from glycosides such as ranunculin when plant tissues are macerated, protoanemonin is a potent vesicant that primarily irritates the mucous membranes of the digestive system. Effects on the urinary system, mammary glands, and brain associated with ingestion of especially large amounts of plant material have also been reported. Protoanemonin is subsequently polymerized to the inactive anemonin, the form found in dried plants.
All buttercups contain ranunculin. When the leaves are crushed or bruised, ranunculin breaks down to form an acrid, toxic oil called protoanemonin. Contact with this oil causes dermatitis. Symptoms occur within an hour of contact and include burning and itching along with rashes and blisters.
Protoanemonin has vesicant properties, which cause rashes or blistering upon contact with the skin or mucosa.
When the leaves are chewed, blisters can form on the lips and face. If swallowed, severe gastrointestinal irritation can follow, accompanied by dizziness, spasms, and paralysis. The toxic oil is also irritating to the eyes.
Ingesting large amounts of the toxin despite its bitter taste can cause nausea, vomiting, dizziness, spasms, acute hepatitis, jaundice, or paralysis in animals and humans.
Ranunculus species vary in their levels of the toxic compound, and individual plants are said to be more toxic in the spring when they are actively growing and flowering. Protoanemonin breaks down further into an innocuous compound called anemonin, so dead and dried-out plants are generally safe.
An important and non-intuitive safety finding concerns the heat stability of protoanemonin: Protoanemonin is heat-resistant and can cause chemical burns even after boiling. Fresh plant preparations seem to cause more adverse effects than dried or boiled preparations. Although the primary toxic substance, protoanemonin, has been reported to be absent in dried or boiled plants, cases of skin burns have been reported with the boiled plant in Turkey.
The toxicity of Ranunculus species seems to be more of an issue for livestock than for humans. Grazing animals tend to avoid it since it tastes so bad. Those that do eat it exhibit responses similar to humans — blistering around the mouth, gastrointestinal issues, etc.
The bitter taste of the protoanemonin can also be passed through the milk of lactating animals. Abortions have been reported in horses and cows maintained in pastures heavily infested with Ranunculus bulbosus L. and Ranunculus acris, respectively.
The seed is the documented edible part and must be cooked. It is used as piñole either on its own or mixed with other seeds; however, the seed must be parched in order to remove an acrid principle. This means that raw, unprocessed seeds of R. occidentalis are not safe for consumption, consistent with the general toxicological profile of the genus.
Western buttercup (Ranunculus occidentalis) has not been assessed or approved as a dietary supplement ingredient by the U.S. Food and Drug Administration, the European Medicines Agency, the European Food Safety Authority, or any other major regulatory body. It is not the subject of a German Commission E monograph, an ESCOP monograph, or a WHO herbal monograph. No maximum tolerable intake level has been established. There are no documented drug–herb interaction studies specific to this species.
While not a pharmacological topic, it is botanically relevant that western buttercup plays an important ecological role in its native range. R. occidentalis's shiny, yellow, five-petaled flowers are an excellent source of early-season pollen for native sweat bees, mining bees, mason bees, bumblebees, and hoverflies. Ranunculus occidentalis is a facultative wetland species, meaning throughout most of its native range it occurs in moist wetland areas or vernal pools, but also sometimes occurs in uplands.
Health conditions that Western buttercup may help support.
Body systems that Western buttercup may help support.
Go back